Nucleic Acid Based Gene
Therapy Global Market
Report 2021: COVID-19
Growth And Change To
2030
@The Business Research Company. All rights reserved.
Nucleic Acid Based Gene Therapy Market Characteristics:
The global nucleic acid based gene therapy market is expected to grow from $0.56 billion in 2020 to $0.61 billion in
2021 at a compound annual growth rate (CAGR) of 8.9%. The growth is mainly due to the companies resuming their
operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to
restrictive containment measures involving social distancing, remote working, and the closure of commercial activities
that resulted in operational challenges. The nucleic acid-based gene therapy market is expected to reach $0.85 billion
in 2025 at a CAGR of 9%.
The report covers the Nucleic Acid Based Gene Therapy market’s segments-
By Technology
By Application
By End User
Anti-Sence and Anti-
Gene, Short
Inhibitory
Sequences, Gene
Transfer Therapy,
Nucleoside Analogs,
Ribozymes
Oncology,
Muscular
Dystrophy/
Muscular
Disorders, Rare
Diseases
Hospitals And
Clinics, Academic
And Research
Institutes
Xx xxxx
Xxxxx, Xxxxxxxx,
Xxxx
Xx xxxx
Xxxxx,
Xxxxxxxx,
Xxxx
Xx xxxx
Xxxxx,
Xxxxxxxx,
Xxxx
@The Business Research Company. All rights reserved.
Nucleic Acid Based Gene Therapy Global Market Report
2021 is the most comprehensive report available on this
market and will help gain a truly global perspective as it
covers 60 geographies.
The chapter on the impact of COVID-19 gives valuable
insights on supply chain disruptions, logistical challenges, and
other economic implications of the virus on the market. The
chapter also covers markets which have been positively
affected by the pandemic.
Click Here To View Complete Report
@The Business Research Company. All rights reserved.
Major Key Players
Major companies in the market include
Click Here To Get
A Sample Report
Wave Life Sciences
Imugene
Caperna
Phylogica
Protagonist Therapeutics
@The Business Research Com